Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer
暂无分享,去创建一个
N. Lee | I. Ganly | N. Riaz | S. McBride | A. Shaha | E. Sherman | C. Tsai | J. Kang | Jennifer Ma | B. Lok | J. Leeman | C. J. Tsai | E. Anderson | D. Fan | A. Bell | Andries H Groen | Kyrie S Olsen
[1] J. Shah,et al. NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.
[2] D. Schomer,et al. Imaging of Anaplastic Thyroid Carcinoma , 2017, American Journal of Neuroradiology.
[3] M. Rivera,et al. Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer , 2017, The Journal of clinical endocrinology and metabolism.
[4] K. Hess,et al. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. , 2017, Thyroid : official journal of the American Thyroid Association.
[5] A. Garden,et al. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base , 2017, Cancer.
[6] C. Sander,et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. , 2016, The Journal of clinical investigation.
[7] Donavan T. Cheng,et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.
[8] J. Shah,et al. Anaplastic Thyroid Carcinoma: A 25-year Single-Institution Experience , 2014, Annals of Surgical Oncology.
[9] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[10] M. Boscaro,et al. Anaplastic Thyroid Carcinoma , 2012, Front. Endocrin..
[11] J. Brierley,et al. The role of external beam radiation and targeted therapy in thyroid cancer. , 2012, Seminars in radiation oncology.
[12] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[13] S. Lim,et al. Treatment Outcome of Patients with Anaplastic Thyroid Cancer: A Single Center Experience , 2012, Yonsei medical journal.
[14] N. Lee,et al. Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] R. Smallridge,et al. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy. , 2011, Thyroid : official journal of the American Thyroid Association.
[16] T. Yau,et al. Treatment Outcomes in Anaplastic Thyroid Carcinoma: Survival Improvement in Young Patients With Localized Disease Treated by Combination of Surgery and Radiotherapy , 2008, Annals of Surgical Oncology.
[17] A. Shaha,et al. Anaplastic Thyroid Carcinoma: Biology, Pathogenesis, Prognostic Factors, and Treatment Approaches , 2006, Annals of Surgical Oncology.
[18] E. Kebebew,et al. Anaplastic thyroid carcinoma , 2005, Cancer.
[19] E. Baudin,et al. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. , 2004, International Journal of Radiation Oncology, Biology, Physics.
[20] P. Xia,et al. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. , 2003, International journal of radiation oncology, biology, physics.
[21] D P Dearnaley,et al. Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] J. Quivey,et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival , 2001, Cancer.
[23] H. Gharib,et al. Anaplastic thyroid carcinoma: current diagnosis and treatment. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] P. Xia,et al. Dose optimization for the treatment of anaplastic thyroid carcinoma: a comparison of treatment planning techniques. , 2000, International journal of radiation oncology, biology, physics.
[25] R. Leeper,et al. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy , 1987, Cancer.
[26] A R Feinstein,et al. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. , 1985, The New England journal of medicine.
[27] H. Chandler. Data Base , 1985, Journal of learning disabilities.
[28] Jae Ho Kim,et al. Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination adriamycin and radiation therapy a new approach , 1982, Cancer.
[29] M. Ranney,et al. Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.
[30] Y. Nikiforov,et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. , 2012, Thyroid : official journal of the American Thyroid Association.